However, a number of anti-tumor antibodies target molecules expressed by tumor cells belonging to the hematopoietic lineage and, hence, also target their normal cell counterparts, notably lymphocytes (anti-CD20, -CD52, -CD38, SLAMF7, etc.)and myeloid cells (anti-CD30, -CD33, etc.). Here, CD33 is linked to neoplasm.